PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.\', \'Children\'s Clinic of Tartu University Hospital, Tartu, Estonia.\', \'Department of Pediatrics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.\', \'SYNLAB Estonia, Veerenni 53a, Tallinn, Estonia.\', \'Department of Biochemistry, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.\', \'Department of Epidemiology and Biostatistics, Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/23744235.2021.1974540
?:hasPublicationType
?:journal
  • Infectious diseases (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34520315
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34520315>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34520315>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all